Matthys KE - Search Results

1

Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients.

Lins RL, Matthys KE, Verpooten GA, Peeters PC, Dratwa M, Stolear JC, Lameire NH. Lins RL, et al. Among authors: matthys ke. Nephrol Dial Transplant. 2003 May;18(5):967-76. doi: 10.1093/ndt/gfg048. Nephrol Dial Transplant. 2003. PMID: 12686673 Clinical Trial.

2

Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study.

Lins RL, Matthys KE, Billiouw JM, Dratwa M, Dupont P, Lameire NH, Peeters PC, Stolear JC, Tielemans C, Maes B, Verpooten GA, Ducobu J, Carpentier YA. Lins RL, et al. Among authors: matthys ke. Clin Nephrol. 2004 Oct;62(4):287-94. doi: 10.5414/cnp62287. Clin Nephrol. 2004. PMID: 15524059 Clinical Trial.

3

Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin.

Vrijens B, Belmans A, Matthys K, de Klerk E, Lesaffre E. Vrijens B, et al. Pharmacoepidemiol Drug Saf. 2006 Feb;15(2):115-21. doi: 10.1002/pds.1198. Pharmacoepidemiol Drug Saf. 2006. PMID: 16342302 Clinical Trial.

4

Antiatherosclerotic activity of drugs in relation to nitric oxide function.

Bult H, Herman AG, Matthys KE. Bult H, et al. Among authors: matthys ke. Eur J Pharmacol. 1999 Jun 30;375(1-3):157-76. doi: 10.1016/s0014-2999(99)00328-3. Eur J Pharmacol. 1999. PMID: 10443573 Review.

5

Dual effects of oxidized low-density lipoprotein on immune-stimulated nitric oxide and prostaglandin release in macrophages.

Matthys KE, Van Hove CE, Jorens PG, Rosseneu M, Marescau B, Herman AG, Bult H. Matthys KE, et al. Eur J Pharmacol. 1996 Feb 29;298(1):97-103. doi: 10.1016/0014-2999(95)00810-1. Eur J Pharmacol. 1996. PMID: 8867925

6

The protective role of thiols against nitric oxide-mediated cytotoxicity in murine macrophage J774 cells.

Zamora R, Matthys KE, Herman AG. Zamora R, et al. Among authors: matthys ke. Eur J Pharmacol. 1997 Feb 19;321(1):87-96. doi: 10.1016/s0014-2999(96)00918-1. Eur J Pharmacol. 1997. PMID: 9083790

7

Nitric oxide function in atherosclerosis.

Matthys KE, Bult H. Matthys KE, et al. Mediators Inflamm. 1997;6(1):3-21. doi: 10.1080/09629359791875. Mediators Inflamm. 1997. PMID: 18472828 Free PMC article.

8

Local application of LDL promotes intimal thickening in the collared carotid artery of the rabbit.

Matthys KE, Van Hove CE, Kockx MM, Andries LJ, Van Osselaer N, Herman AG, Bult H. Matthys KE, et al. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2423-9. doi: 10.1161/01.atv.17.11.2423. Arterioscler Thromb Vasc Biol. 1997. PMID: 9409211

9

Exposure to oxidized low-density lipoprotein in vivo enhances intimal thickening and selectively impairs endothelium-dependent dilation in the rabbit.

Matthys KE, Van Hove CE, Kockx MM, Andries LJ, Van Osselaer N, Herman AG, Bult H. Matthys KE, et al. Cardiovasc Res. 1998 Jan;37(1):239-46. doi: 10.1016/s0008-6363(97)00202-2. Cardiovasc Res. 1998. PMID: 9539879

10

Involvement of 5-HT1B receptors in collar-induced hypersensitivity to 5-hydroxytryptamine of the rabbit carotid artery.

Geerts IS, Matthys KE, Herman AG, Bult H. Geerts IS, et al. Among authors: matthys ke. Br J Pharmacol. 1999 Jul;127(6):1327-36. doi: 10.1038/sj.bjp.0702684. Br J Pharmacol. 1999. PMID: 10455282 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters